Night Respite for Postpartum Mothers With SUD
Opioid Use Disorder, Maternal Drugs Affecting Fetus, Postpartum Mood Disturbance
About this trial
This is an interventional treatment trial for Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria: Caring for an infant under 12 months of age. Being the primary caretaker for their infant. Having a DSM-5 diagnosis of a substance use disorder. Currently residing in a participating residential treatment program English-speaking or Spanish-speakers with limited English proficiency Exclusion Criteria: Having an untreated serious mental health illness. Having an untreated substance use disorder or existing concerns that this person is actively using substances. Having a history of prior violence or intimate partner violence in the home. Provider concern regarding instability or lack of information about home safety. Not actively parenting an infant under 12 months of age
Sites / Locations
- Entre Familia Residential Treatment ProgramRecruiting
- New Day Residential Treatment ProgramRecruiting
Arms of the Study
Arm 1
Experimental
Night Respite Care
18 overnight night respite care sessions over six weeks with parental skills provided through teachable moments before and after respite care supports